JONES FINANCIAL COMPANIES LLLP

Position in ARGX — Argenx SE

CIK 815917 DES PERES, MO

Position in ARGX

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$13,598,324

+$1,323,553 QoQ

Shares Held

14,657

-12.8% QoQ

Ownership

0.024%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

#109

of 504 holders

Holding Since

Sep 2023

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

JONES FINANCIAL COMPANIES LLLP holds $339,789,023 across 287 Biotechnology names. ARGX ranks #6 (4.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	215,419	$107,005,079
2	TECH	BIO-TECHNE Corp	797,001	$56,308,120
3	SLS	SELLAS Life Sciences Group, Inc.	2,304,561	$34,015,320
4	ALNY	Alnylam Pharmaceuticals, Inc.	80,491	$24,230,204
5	REGN	Regeneron Pharmaceuticals, Inc.	28,691	$17,889,985
6	ARGX	Argenx SE This page	14,657	$13,598,324
7	ARDX	Ardelyx, Inc.	1,765,932	$9,006,253
8	INSM	INSMED Inc	68,803	$7,335,774

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$13,598,324	14,657	-12.8%	Shares	Sole	2026-08-14
2026-03-31	$12,274,771	16,809	+2923.2%	Shares	Sole	2026-05-15
2025-12-31	$467,567	556	+104.4%	Shares	Sole	2026-02-17
2025-09-30	$200,616	272	+134.5%	Shares	Sole	2025-11-04
2025-06-30	$63,941	116	-38.3%	Shares	Sole	2025-08-13
2025-03-31	$111,270	188	+180.6%	Shares	Sole	2025-05-28
2024-12-31	$41,205	67	+1016.7%	Shares	Sole	2025-02-06
2024-09-30	$3,252	6	+200.0%	Shares	Sole	2024-11-12
2024-03-31	$787	2	-71.4%	Shares	Sole	2024-05-14
2023-12-31	$2,663	7	+600.0%	Shares	Sole	2024-02-13
2023-09-30	$491	1	—	Shares	Sole	2023-11-14
No filing history on record for this holder in this stock.